Evaluation of MELD for prediction of mortality in decompensated chronic hepatitis B [1]

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 455-

  Navaneethan, U ^a   Jayanthi, V ^b  

^a MADRAS MEDICAL COLLEGE   (India)

^b STANLEY MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE;

ASCITES; BACTERIAL INFECTION; BLEEDING; DISEASE SEVERITY; HEART REPOLARIZATION; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; HYPERTENSION; LETTER; LIVER CELL CARCINOMA; LIVER FAILURE; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; PERITONITIS; PORTAL VEIN BLOOD PRESSURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

DISEASE PROGRESSION; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 33846554736     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00904_1.x     Document Type: Letter

References (8)

1. Chan HL, Chim AM, Lau JT, et al. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol 2006;101:1516-23.
2. Bernardi M, Calandra S, Colantoni A, et al. Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998;27:28-34.
3. Ytting H, Henriksen JH, Fuglsang S, et al. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J Hepatol 2005;43:637-44.
4. Puthumana L, Chaudhry V, Thuluvath PJ. Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis. J Hepatol 2001;35:733-8.
5. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
6. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006;20:188-94.
7. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003;98:1395-9.
8. Udayakumar N, Jayanthi V. Mayo clinic model of end stage liver disease (MELD) for predicting outcome in patients with hepatic encephalopathy. J Clin Gastroenterol 2006 [in press].